Product Description
Highlighted as a first-class, directly compressible grade, Paracetamol IP BP USP DC 90% API is trending among leading pharmaceutical manufacturers. This distinguished active pharmaceutical ingredient is championed for its exceptional purity (99.0% on a dried basis) and strict compliance with IP/BP/USP requirements. Delivered with a batch-specific Certificate of Analysis (COA), it offers reliable quality for tablet formulations. Its competitive bulk and tapped density, quick disintegration time, and low impurity profile make it a top choice for effective medicinal products. Secure packaging and extended shelf life enhance its appeal for distributors and exporters.
Commercial Application & Competitive Edge of Paracetamol IP BP USP DC 90% API
Paracetamol IP BP USP DC 90% API is widely utilized in pharmaceutical tablet manufacturing, on account of its directly compressible properties and high assay range. Ideal for commercial-scale production environments such as large contract manufacturing organizations and pharmaceutical facilities, it stands out for its rapid tablet disintegration, compliance with global pharmacopoeias, and minimal related substances. Its competitive advantages include consistently high batch quality, ease of formulation, and reliable, accurate dosing, distinguishing it as an industry standard.
Export Markets, Sample Policy, and Delivery Details for Paracetamol API
With a thriving export network extending across Asia, Africa, the Middle East, South America, and Europe, Paracetamol IP BP USP DC 90% API is delivered with an emphasis on both speed and security. Sample quantities can be provided on request, allowing prospective partners to assess quality before expenditure. Competitive quotations are readily available, and standard delivery times are efficiently managed to meet timely production schedules, ensuring a reliable supply chain.
FAQ's of Paracetamol IP BP USP DC 90% API with COA:
Q: How can I use Paracetamol IP BP USP DC 90% API in pharmaceutical formulations?
A: Paracetamol IP BP USP DC 90% API is ideal for direct tablet compression in pharmaceutical manufacturing, simplifying the process and ensuring uniform dosage in each tablet produced.
Q: What quality certifications does this product meet?
A: This API meets stringent Indian, British, and US Pharmacopoeia (IP/BP/USP) standards, and each batch is supplied with a detailed Certificate of Analysis (COA) for full compliance assurance.
Q: When is the Certificate of Analysis provided?
A: The Certificate of Analysis is supplied with every batch upon delivery, confirming the product's conformity to required specifications and regulatory standards.
Q: Where can this API be applied commercially?
A: Paracetamol IP BP USP DC 90% API is extensively used in pharmaceutical manufacturing plants, contract manufacturing organizations, and export-focused pharmaceutical hubs.
Q: What are the storage and shelf life requirements of this API?
A: Store in well-closed containers at room temperature, protected from light and moisture. The product maintains its distinguished quality for up to 60 months (5 years) from the date of manufacture.
Q: How does the directly compressible grade benefit tablet production?
A: The directly compressible (DC) grade enables efficient, high-speed tablet formation without the need for granulation, reducing production time while maintaining tablet integrity and performance.